Expert Review of Pharmacoeconomics and Outcomes Research This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
Description of characteristics, management of care and healthcare direct costs of patients with HR+/HER2- early breast cancer in Italy: a real-world study involving administrative and pathological anatomy databases
CONCLUSIONS: One in ten patients with EBC who underwent LN removal experienced a relapse, highlighting the strong need to prevent early recurrence.PMID:37638590 | DOI:10.1080/14737167.2023.2246652 (Source: Expert Review of Pharmacoeconomics and Outcomes Research)
Source: Expert Review of Pharmacoeconomics and Outcomes Research - August 28, 2023 Category: Health Management Authors: Valentina Perrone Elisa Giacomini Diego Sangiorgi Antonella Tamma Massimo Giovannitti Carlotta Buzzoni Luca Degli Esposti Source Type: research
An exploratory cost-effectiveness analysis of a novel tissue valve compared with mechanical valves for surgical aortic valve replacement in subgroups of people aged 55-64 and 65+ with aortic stenosis in the UK
CONCLUSIONS: The exploratory analysis suggests that the novel tissue valve could be a cost-effective intervention for people over the age of 55 with AS who are suitable for SAVR in the UK.PMID:37638585 | DOI:10.1080/14737167.2023.2249611 (Source: Expert Review of Pharmacoeconomics and Outcomes Research)
Source: Expert Review of Pharmacoeconomics and Outcomes Research - August 28, 2023 Category: Health Management Authors: Robert Malcolm Ciara Buckley Judith Shore Angela Stainthorpe Belen Marti Andrea White Jens Deckert Matteo Vernia Jo ão L Carapinha Ana L ópez-Marco Nicolas Nikolaidis Olaf Wendler Source Type: research
Description of characteristics, management of care and healthcare direct costs of patients with HR+/HER2- early breast cancer in Italy: a real-world study involving administrative and pathological anatomy databases
CONCLUSIONS: One in ten patients with EBC who underwent LN removal experienced a relapse, highlighting the strong need to prevent early recurrence.PMID:37638590 | DOI:10.1080/14737167.2023.2246652 (Source: Expert Review of Pharmacoeconomics and Outcomes Research)
Source: Expert Review of Pharmacoeconomics and Outcomes Research - August 28, 2023 Category: Health Management Authors: Valentina Perrone Elisa Giacomini Diego Sangiorgi Antonella Tamma Massimo Giovannitti Carlotta Buzzoni Luca Degli Esposti Source Type: research
An exploratory cost-effectiveness analysis of a novel tissue valve compared with mechanical valves for surgical aortic valve replacement in subgroups of people aged 55-64 and 65+ with aortic stenosis in the UK
CONCLUSIONS: The exploratory analysis suggests that the novel tissue valve could be a cost-effective intervention for people over the age of 55 with AS who are suitable for SAVR in the UK.PMID:37638585 | DOI:10.1080/14737167.2023.2249611 (Source: Expert Review of Pharmacoeconomics and Outcomes Research)
Source: Expert Review of Pharmacoeconomics and Outcomes Research - August 28, 2023 Category: Health Management Authors: Robert Malcolm Ciara Buckley Judith Shore Angela Stainthorpe Belen Marti Andrea White Jens Deckert Matteo Vernia Jo ão L Carapinha Ana L ópez-Marco Nicolas Nikolaidis Olaf Wendler Source Type: research
Description of characteristics, management of care and healthcare direct costs of patients with HR+/HER2- early breast cancer in Italy: a real-world study involving administrative and pathological anatomy databases
CONCLUSIONS: One in ten patients with EBC who underwent LN removal experienced a relapse, highlighting the strong need to prevent early recurrence.PMID:37638590 | DOI:10.1080/14737167.2023.2246652 (Source: Expert Review of Pharmacoeconomics and Outcomes Research)
Source: Expert Review of Pharmacoeconomics and Outcomes Research - August 28, 2023 Category: Health Management Authors: Valentina Perrone Elisa Giacomini Diego Sangiorgi Antonella Tamma Massimo Giovannitti Carlotta Buzzoni Luca Degli Esposti Source Type: research
Cost-utility analysis of multiple sclerosis rehabilitation in Iran
CONCLUSIONS: The MS multidisciplinary rehabilitation proved to be a cost-effective strategy; however, the results were sensitive to the input values of the model. Increasing the time horizon increased the probability of rehabilitation being cost-effective.PMID:37614049 | DOI:10.1080/14737167.2023.2251689 (Source: Expert Review of Pharmacoeconomics and Outcomes Research)
Source: Expert Review of Pharmacoeconomics and Outcomes Research - August 24, 2023 Category: Health Management Authors: Rajabali Daroudi Mirtaher Mousavi Marzieh Shirazikhah Mehdi Alizadeh Zarei Hamidreza Hendi Faezeh Joghataei Ali Darvishi Source Type: research
Unwanted outcomes in cognitive behavior therapy for pathological health anxiety: a systematic review and a secondary original study of two randomized controlled trials
Expert Rev Pharmacoecon Outcomes Res. 2023 Aug 24:1-15. doi: 10.1080/14737167.2023.2250915. Online ahead of print.ABSTRACTINTRODUCTION: Cognitive behavior therapy (CBT) is effective for pathological health anxiety, but little is known about unwanted outcomes.AREAS COVERED: We investigated unwanted outcomes in the form of adverse events, overall symptom deterioration, and dropouts in CBT for pathological health anxiety based on a systematic review of 19 randomized controlled trials (PubMed, PsycInfo, and OATD; last updated 2 June 2023; pooled N = 2188), and then a secondary original study of two randomized controlled trials...
Source: Expert Review of Pharmacoeconomics and Outcomes Research - August 24, 2023 Category: Health Management Authors: Erland Axelsson Erik Hedman-Lagerl öf Source Type: research
Cost-Utility analysis of Multiple Sclerosis rehabilitation in Iran
CONCLUSIONS: The MS multidisciplinary rehabilitation proved to be a cost-effective strategy; however, the results were sensitive to the input values of the model. Increasing the time horizon increased the probability of rehabilitation being cost-effective.PMID:37614049 | DOI:10.1080/14737167.2023.2251689 (Source: Expert Review of Pharmacoeconomics and Outcomes Research)
Source: Expert Review of Pharmacoeconomics and Outcomes Research - August 24, 2023 Category: Health Management Authors: Rajabali Daroudi Mirtaher Mousavi Marzieh Shirazikhah Mehdi Alizadeh Zarei Hamidreza Hendi Faezeh Joghataei Ali Darvishi Source Type: research
Unwanted outcomes in cognitive behavior therapy for pathological health anxiety: a systematic review and a secondary original study of two randomized controlled trials
Expert Rev Pharmacoecon Outcomes Res. 2023 Aug 24:1-15. doi: 10.1080/14737167.2023.2250915. Online ahead of print.ABSTRACTINTRODUCTION: Cognitive behavior therapy (CBT) is effective for pathological health anxiety, but little is known about unwanted outcomes.AREAS COVERED: We investigated unwanted outcomes in the form of adverse events, overall symptom deterioration, and dropouts in CBT for pathological health anxiety based on a systematic review of 19 randomized controlled trials (PubMed, PsycInfo, and OATD; last updated 2 June 2023; pooled N = 2188), and then a secondary original study of two randomized controlled trials...
Source: Expert Review of Pharmacoeconomics and Outcomes Research - August 24, 2023 Category: Health Management Authors: Erland Axelsson Erik Hedman-Lagerl öf Source Type: research
Cost-Utility analysis of Multiple Sclerosis rehabilitation in Iran
CONCLUSIONS: The MS multidisciplinary rehabilitation proved to be a cost-effective strategy; however, the results were sensitive to the input values of the model. Increasing the time horizon increased the probability of rehabilitation being cost-effective.PMID:37614049 | DOI:10.1080/14737167.2023.2251689 (Source: Expert Review of Pharmacoeconomics and Outcomes Research)
Source: Expert Review of Pharmacoeconomics and Outcomes Research - August 24, 2023 Category: Health Management Authors: Rajabali Daroudi Mirtaher Mousavi Marzieh Shirazikhah Mehdi Alizadeh Zarei Hamidreza Hendi Faezeh Joghataei Ali Darvishi Source Type: research
Unwanted outcomes in cognitive behavior therapy for pathological health anxiety: a systematic review and a secondary original study of two randomized controlled trials
Expert Rev Pharmacoecon Outcomes Res. 2023 Aug 24:1-15. doi: 10.1080/14737167.2023.2250915. Online ahead of print.ABSTRACTINTRODUCTION: Cognitive behavior therapy (CBT) is effective for pathological health anxiety, but little is known about unwanted outcomes.AREAS COVERED: We investigated unwanted outcomes in the form of adverse events, overall symptom deterioration, and dropouts in CBT for pathological health anxiety based on a systematic review of 19 randomized controlled trials (PubMed, PsycInfo, and OATD; last updated 2 June 2023; pooled N = 2188), and then a secondary original study of two randomized controlled trials...
Source: Expert Review of Pharmacoeconomics and Outcomes Research - August 24, 2023 Category: Health Management Authors: Erland Axelsson Erik Hedman-Lagerl öf Source Type: research
Cost-Utility analysis of Multiple Sclerosis rehabilitation in Iran
CONCLUSIONS: The MS multidisciplinary rehabilitation proved to be a cost-effective strategy; however, the results were sensitive to the input values of the model. Increasing the time horizon increased the probability of rehabilitation being cost-effective.PMID:37614049 | DOI:10.1080/14737167.2023.2251689 (Source: Expert Review of Pharmacoeconomics and Outcomes Research)
Source: Expert Review of Pharmacoeconomics and Outcomes Research - August 24, 2023 Category: Health Management Authors: Rajabali Daroudi Mirtaher Mousavi Marzieh Shirazikhah Mehdi Alizadeh Zarei Hamidreza Hendi Faezeh Joghataei Ali Darvishi Source Type: research
Unwanted outcomes in cognitive behavior therapy for pathological health anxiety: a systematic review and a secondary original study of two randomized controlled trials
Expert Rev Pharmacoecon Outcomes Res. 2023 Aug 24:1-15. doi: 10.1080/14737167.2023.2250915. Online ahead of print.ABSTRACTINTRODUCTION: Cognitive behavior therapy (CBT) is effective for pathological health anxiety, but little is known about unwanted outcomes.AREAS COVERED: We investigated unwanted outcomes in the form of adverse events, overall symptom deterioration, and dropouts in CBT for pathological health anxiety based on a systematic review of 19 randomized controlled trials (PubMed, PsycInfo, and OATD; last updated 2 June 2023; pooled N = 2188), and then a secondary original study of two randomized controlled trials...
Source: Expert Review of Pharmacoeconomics and Outcomes Research - August 24, 2023 Category: Health Management Authors: Erland Axelsson Erik Hedman-Lagerl öf Source Type: research
Cost-effectiveness of tumor necrosis factor-alpha inhibitors: a systematic review and meta-analysis of cost-utility studies
CONCLUSION: Based on the available evidence during the study period, TNF-a-i is not a cost-effective option for treating RA compared to other DMARDs. However, high heterogeneity and low confidence in GRADE quality assessment preclude the results from being generalizable.PMID:37604704 | DOI:10.1080/14737167.2023.2249610 (Source: Expert Review of Pharmacoeconomics and Outcomes Research)
Source: Expert Review of Pharmacoeconomics and Outcomes Research - August 21, 2023 Category: Health Management Authors: Sajith Kumar Bhavani Shankara Bagepally Source Type: research